Welcome to LookChem.com Sign In|Join Free

CAS

  • or

88917-69-5

Post Buying Request

88917-69-5 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

88917-69-5 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 88917-69-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 8,8,9,1 and 7 respectively; the second part has 2 digits, 6 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 88917-69:
(7*8)+(6*8)+(5*9)+(4*1)+(3*7)+(2*6)+(1*9)=195
195 % 10 = 5
So 88917-69-5 is a valid CAS Registry Number.

88917-69-5SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name diethyl-[2-(4-isothiocyanato-phenoxy)-ethyl]-amine

1.2 Other means of identification

Product number -
Other names Diaethyl-[2-(4-isothiocyanato-phenoxy)-aethyl]-amin

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:88917-69-5 SDS

88917-69-5Relevant articles and documents

THIAZOLE AND PYRAZOLE DERIVATIVES AS FLT-3 KINASE INHIBITORS

-

Page/Page column 49, (2010/02/11)

The invention relates to thiazole and pyrazole derivatives of formula (I) wherein Q is S and X is C, or Q is CH and X is N; R1 is unsubtituted or substituted phenyl; and R2 is unsubstituted or substituted aryl or heteroaryl; oa a salt of the said compounds, and to processes for the preparation thereof, to pharmaceutical compositions comprising such derivatives and to the use of such derivatives for the preparation of pharmaceutical compositions for the treatment especially of a proliferative disease, such as a tumour disease, in particular such diseases which respond to an inhibition of the FIt-3 kinase.

Some aryloxyalkylamines, N-arylethylenediamines, and related compounds as anorectic agents.

Shadbolt,Sharpe,Brown,Ashford,Ross

, p. 836 - 842 (2007/10/06)

-

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 88917-69-5